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Stereoselective chemo-enzymatic
oxidation routes for
(1R,3E,7E,11S,12S)-3,7,18-
dolabellatriene
Christian Görner, Max Hirte, Stephanie Huber, Patrick Schrepfer and Thomas Brück*
Fachgebiet für Industrielle Biokatalyse, Department für Chemie, Technische Universität München, Garching, Germany
The diterpene (1R,3E,7E,11S,12S)-3,7,18-dolabellatriene from the marine brown alga
Dilophus spiralis belongs to the dolabellanes natural product family and has antimicrobial
activity against multi-drug resistant Staphylococcus aureus. Recently, we generated
a CotB2 diterpene synthase mutant (W288G), which instead of its native product
cyclooctat-9-en-7-ol, generates (1R,3E,7E,11S,12S)-3,7,18-dolabellatriene. In vivo
CotB2 W288G reconstitution in an Escherichia coli based terpene production system,
allowed efficient production of this olefinic macrocycle. To diversify the 3,7,18-
dolabellatriene bioactivity we evaluated chemical and enzymatic methods for selective
oxidation. Epoxidation by acetic peracid, which was formed in situ by a lipase catalyzed
reaction of acetic acid with H2O2, provided efficient access to two monooxidized
dolabellanes and to a novel di-epoxidated dolabellane species. These compounds
could act as synthons en-route to new dolabellanes with diversified bioactivities.
Furthermore, we demonstrate the almost quantitative 3,7,18-dolabellatriene conversion
into the new, non-natural compound (1R,3E,7E,11S,12S,18R)-dolabella-3,7-diene-20-
ol by hydroboration–oxidation with an enantiomeric excess of 94%, for the first
time.
Keywords: diterpenes, dolabellanes, chemo-enzymatic synthesis, hydroboration, epoxidation
INTRODUCTION
Dolabellane diterpenoids have originally been reported in the herbivor sea hare Dolabella
california (Ireland and Faulkner, 1977). In later studies marine algae, sponges, and
terrestrial plants such as liverworts were found to be rich sources of dolabellane
natural products (Cai et al., 2010). All dolabellane diterpenoids share a 5,11-bicyclic
skeleton and are frequently functionalized by hydroxyl, epoxide, and glucoside groups.
The dolabellane family is known for its broad spectrum of biological activities (see
Figure 1) encompassing antiviral (1) (Cirne-Santos et al., 2008), antibacterial (2),
(4–6) (Ioannou et al., 2011), cytotoxic (3) (Duh et al., 2001), molluscicidal, and phytotoxic
activity (Piattelli et al., 1995).
The eﬃcient total chemical synthesis or biotechnological production process for structurally
complex terpenoids such as dolabellanes, arteminisin, or taxol remains challenging (Kusama et al.,
2000; Lozama and Prisinzano, 2009; Malik et al., 2011). Total chemical synthesis of functionalized
natural products often involves multiple steps, resulting in racemic intermediates, and low product
yields. In this respect, the synthetic assembly of oleﬁnic macrocycles containing numerous
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FIGURE 1 | Bioactive dolabellane structures. (1) from the brown alga
Dictyota pfaffii inhibits the replication of the Human immunodeficiency virus
type-1 (HIV-1). (2,4,5,6) from the brown alga Dilophus spiralis display
antimicrobial activity against Staphylococcus aureus. (3) isolated from the soft
coral Clavularia inflate exerts cytotoxic activity against human lung carcinoma
cells.
stereocenters and often display elaborate functionalization
patterns, such as glycosylation or addition of aromatic residues,
are particularly demanding. Biotechnological routes for
stereoselective production of functionalized terpenes are an
increasingly attractive alternative to synthetic chemistry but
at present remain rather ineﬃcient (Brück et al., 2014). While
biosynthetic routes for generation of oleﬁnic terpene macrocycles
in heterologous microbial production systems gain signiﬁcant
momentum due to advances in synthetic biotechnology (Leonard
et al., 2010), the identiﬁcation and reconstitution of enzymes that
functionalize terpene macrocycles in the desired heterologous
production host, remains a bottleneck (Brück et al., 2014). In
particular, eﬃcient application of speciﬁc P450-type enzyme
activities that can hydroxylate aliphatic diterpene macrocycles,
en-route to highly functionalized terpenoids, often fail in
target-oriented biosynthesis approaches (Zhang et al., 2011).
A strategy to circumvent these obstacles, is the eﬃcient cell
based production of terpene macrocycles in suitable Escherichia
coli or Saccharomyces cerevisiae production strains (Engels et al.,
2008; Ajikumar et al., 2010; Brück et al., 2014), followed by
in vitro functionalization utilizing various chemical or enzymatic
processes. These semisynthetic routes can provide eﬃcient access
to functionalized, bioactive terpenoids, but depend on the
availability of the respective terpene synthase and its functional
reconstitution in an eﬃcient in vivo production system as well as
the implementation of selective chemical synthesis steps.
Several chemical strategies have been used in semisynthetic
approaches to convert terpenoids to diverse compounds.
(Toyooka et al., 1993; Baloglu and Kingston, 1999; Morrison
and Hergenrother, 2014; Turconi et al., 2014). However,
these chemical strategies conventionally rely on available
functionalized precursors, which are derived from isolated
natural products or biotechnological production routes
that provide speciﬁc biosynthetic intermediates. In certain
instances the initial hydroxylation of the macrocycle has been
accomplished by P450 type oxidoreductases (Le-Huu et al.,
2015). By contrast, selective chemical hydroxylation of terpene
macrocycles is extremely challenging due to the presence of
chemically almost equivalent C-H bonds. Nevertheless, allylic
hydroxylation by SeO2-mediated oxidation represent one
successful approach. However, this particular reaction suﬀers
from poor selectivity (Katsuyama et al., 2002).
Due to a lack of a native dolabellane synthase the
biotechnological production of this diterpene macrocycle and its
application in an enzymatic and or a semisynthetic approach
has hitherto not been feasible. However, we could previously
demonstrate that introduction of the mutation W288G in
the diterpene cyclase CotB2, which naturally produces the
structurally related fusicoccan cyclooctat-9-en-7-ol (2b), instead
results in formation of (1R,3E,7E,11S,12S)-3,7,18-dolabellatriene
(2) (Figure 2) (Janke et al., 2014).
The diterpene synthase CotB2 is part of the Streptomyces
melanosporofaciens derived, four component biosynthetic gene
cluster spanning cotB1 to cotB4, which results in formation of
cyclooctatin, a lysophospholipase inhibitor (see Figure 2; Kim
et al., 2009). The reported cyclooctatin biosynthesis pathway
encodes a geranylgeranyl diphosphate synthase (CotB1), a
diterpene synthase (CotB2) and the class I P450 type hydroxylases
CotB3 and CotB4 (Figure 2). Interestingly, (2), which displays
antibacterial activity again multi-drug resistant Staphylococcus
aureus (MRSA) was ﬁrst been reported in the brown algae
Dilophus spiralis. (Ioannou et al., 2011).
The biosynthesis of dolabellane macrocycles starts, like all
terpenes, with the stepwise condensation of the universal terpene
precursors isopentenyl-diphosphate (IPP) and dimethylallyl
diphosphate (DMAPP) yielding the aliphatic diterpene precursor
geranylgeranyldiphosphate (C-20). In the subsequent cyclisation
reaction by a diterpene synthase, a highly reactive carbocation
is created by cleaving of the pyrophosphate group, which
propagates the cyclisation through stepwise stereoselective
connection of the carbon skeleton. The CotB2 W288G mutation
attenuates the cyclisation cascade for the production of
cyclooctat-9-en-7-ol by premature proton elimination (Meguro
et al., 2015) to yield dolabellatriene (Figure 2). In analogy, it
can be assumed that a native dolabellane synthase may have
a similar reaction mechanism. In this study, we applied both
enzymatic and chemical strategies to biotechnological production
of dolabellane (2) in order to provide access to a broad spectrum
of natural and non-natural dolabellanes.
MATERIALS AND METHODS
General Experimental Procedure
All chemicals were obtained from standard sources at the highest
purity grade. NMR spectra were recorded in CDCl3 with an
Avance-III 500 MHz (Bruker) at 300 K. 1H NMR chemical shifts
are given in ppm relative to CHCl3 (δ = 7.26 ppm). 13C NMR
chemical shifts are given in ppm relative to CDCl3 at δ = 77.16.
The 2D experiments (HSQC, COSY, NOESY) were performed
using standard Bruker pulse sequences and parameters.
GC-MS analysis of diterpene products from ethyl acetate
extractions was done by a Trace GC Ultra with DSQII (Thermo
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FIGURE 2 | Biocatalysis and cyclisation mechanism of (1R,3E,7E,11S,12S)-3,7,18-dolabellatriene (2).
Scientiﬁc). One microliter sample was applied by TriPlus AS
onto a SGE BPX5 column (30 m, I.D 0.25 mm, Film 0.25 μm).
The initial column temperature was 50◦C (maintained for
2.5 min). A temperature gradient was applied from 50 to 320◦C
(10◦C/min), followed by 3 min maintenance at 320◦C. MS
data were recorded at 70 eV (EI), m/z (rel. intensity in %) as
TIC, total ion current. The recorded m/z range was 50–650.
Quantiﬁcation was performed with ﬂame ionization detector
(FID) using 1 mg/mL α-humulene (Sigma–Aldrich, Germany) as
an internal standard.
Bacterial Strains, Genes, and Vectors
The E. coli strains XL-1 Blue and BL21 (DE3) were used for
cloning and diterpene production. All strains and plasmids
were obtained from Novagen/Merck Millipore. Genes were
synthesized by Life Technologies GmbH featuring the
appropriate restriction sites and adjusting codon usage for
E. coli.
Plasmids for (1R,3E,7E,11S,12S)-3,7,18-
dolabellatriene Production
The 1-deoxy-D-xylulose 5-phosphate (DXP) pathway was
harbored by the plasmids pCola-Duet-1 and pCDF-Duet-1,
while the geranylgeranyl diphosphate synthase (crtE) and
diterpene synthase cotB2 W288G synthase biosynthesis genes
were carried by the plasmids pET-Duet-1. To overexpress
the DXP pathway in E. coli BL21(DE3), genes from E. coli
encoding for the 1-deoxy-D-xylulose 5-phosphate synthase
(dxs) (GenBank: YP_001461602.1) (Supplementary Figure
S13), 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr)
(GenBank: NP_414715.1) (Supplementary Figure S14), 2-C-
methyl-D-erythriol 4-phosphate cytidyltransferase synthase
(ispD) (GenBank: NP_417227.1) (Supplementary Figure S15),
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (ispF)
(GenBank: NP_289295.1) (Supplementary Figure S15), and
isopentenyl-diphosphate delta isomerase (idi) (GenBank:
NP_417365.1) (Supplementary Figure S16) were synthesized.
IspD/ispF was created as a bi-cistronic operon (Supplementary
Figure S15). The native geranylgeranyl diphosphate synthase
(crtE) (GenBank: M90698.1) sequence was ampliﬁed from
Pantoea agglomerans (ATCC 27155) using standard protocols.
Primers used were 5′-AAA CCA TGG CAA TGG CAA
CGG TCT GCG CA-3′ and 5′-AAA GAA TTC TTA ACT
GAC GGC AGC GAG TTT-3′. The cyclooctat-9-en-7-
ol diterpene synthase cotB2 (GenBank: BAI44338.1) from
Streptomyces melanosporofaciens MI614-43F2 was synthesized
(Supplementary Figure S17). The point mutation W288G in
cotB2 gene for the production of (1R,3E,7E,11S,12S)-3,7,18-
dolabellatriene was introduced by the QuikChange site-directed
mutagenesis protocol. Primers used were: 5′-CTG ATT TAT
GGC AAT TTT GTG GGC ACC ACC TCC AAC AAA CGT
TAT AAA AC-3′ and 5′-GTT TTA TAA CGT TTG TTG GAG
GTG GTG CCC ACA AAA TTG CCA TAA ATC AG-3′. The
synthetic genes and PCR products were introduced into the
appropriate plasmids according to Table 1 by standard cloning
techniques.
Plasmids Used to Evaluate
(1R,3E,7E,11S,12S)-3,7,18-dolabellatriene
Oxidation by P450BM3
For the in vitro and in vivo assay of P450BM3 the native
gene sequence (Genebank: CP009920.1) was ampliﬁed from
Bacillus megaterium by the following primers: 5′- TAT ACC
ATG GCA ATT AAA GAA ATG CCT C-3′ and 5′-ATT AGC
GGC CGC TCA CCC AGC CCA CAC G-3′ using standard
protocols. The gene was cloned into the vectors pET28a
and pACYC-Duet-1 using the restriction sites NcoI and PacI
according standard cloning techniques. Mutant version of
P450BM3 were created in the vectors pET28a and pACYC-Duet-1,
respectively. The mutations F87A and A328 were introduced by
the QuikChange site-directed mutagenesis protocol. Primers for
the F87Amutation was 5′-GCAGGAGACGGGTTAGCGACA
AGC TGG ACG CAT G-3′ and 5′-CAT GCG TCC AGC TTG
TCG CTA ACC CGT CTC CTG C-3′. For the A328L mutation
the following primers were used: 5′-CAT ATA GGG AAA ACG
CAG GCA CAG TTG GCC ATA AGC GCA G-3′ and 5′-CTG
CGC TTA TGG CCA ACT GTG CCT GCG TTT TCC CTA
TAT G-3′.
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TABLE 1 | Plasmids used to construct the pathway for the production of
(1R,3E,7E,11S,12S)-3,7,18-dolabellatriene in Escherichia coli BL21 (DE3).
Gene(s) Vector Multiple cloning site Restriction sites
dxr pCola-Duet-1 I NcoI, EcoRI
dxs pCola-Duet-1 II NdeI, XhoI
ispD/ispF operon pCDF-Duet-1 I NcoI, EcoRI
idi pCDF-Duet-1 II NdeI, XhoI
crtE pET-Duet-1 I NcoI, EcoRI
cotB2 pET-Duet-1 II NdeI, XhoI
Production of (1R,3E,7E,11S,12S)-3,7,18-
dolabellatriene
The vectors pCola-Duet-1 (dxr, dxs), pCDF-Duet-1 (ispD/ispF,
idi), and pET-Duet-1 (crtE, cotB2) were introduced into E. coli
BL21 (DE3) by standard transformation procedures. The cells
were grown in 1 L M9 media supplemented with 1 g/L
casamino acids, 30 μg/mL kanamycin, 50 μg/mL streptomycin,
50 μg/mL, and carbenicillin in 5 L baﬄed glass ﬂasks.
The culture was inoculated at OD600 0.1 from an overnight
culture (8 h cultivation at 37◦C, LB media supplemented with
30 μg/mL kanamycin, 50 μg/mL, streptomycin, and 50 μg/mL
carbenicillin) and cultivated at 37◦C to OD600 0.8. Next,
protein expression was started by adding 0.5 mM isopropyl
β-D-1-thiogalactopyranoside (IPTG). Furthermore, 2% (w/w)
glycerol and 2.5 g/L hydrophobic beads (Polygoprep 60-50
C18, Macherey-Nagel) were supplemented and cultivation was
performed at 28◦C for 5 days. After 3 days additional 2% (w/w)
glycerol were added.
Extraction and Isolation of
(1R,3E,7E,11S,12S)-3,7,18-
dolabellatriene
The hydrophobic beads were recovered by ﬁltration, washed
with water and subsequently dried. Subsequently, these beads
were extracted three times with 200 mL ethyl acetate. The
organic phases were combined, dried with MgSO4. The solid
formed after vacuum evaporation was used in analytical
procedures. GC-MS and -FID analysis was carried out with
the crude extract, which was dissolved in 1 mL ethyl acetate
prior to injection. Puriﬁcation of (1R,3E,7E,11S,12S)-3,7,18-
dolabellatriene was carried out by ﬂash chromatography using
hexane on silica (Silica gel 40, Sigma–Aldrich) as solid
phase.
Epoxidation of (1R,3E,7E,11S,12S)-
3,7,18-dolabellatriene
15 mg (1R,3E,7E,11S,12S)-3,7,18-dolabellatriene was solved in
10 mL ethyl acetate supplemented with 10 μL acetic acid
and 300 mg lipase B resin (lipase acrylic resin from Candida
antarctica, Sigma–Aldrich) and 5 mM 30% H2O2 (aq). The
mixture was incubated at 25◦C for 72 h. For GC-MS and
-FID analysis 200 μl aliquots were taken. Samples were
washed with 500 μL ddH2O and the organic phase was
analyzed. After termination of the reaction, the epoxidated
dolabellane (7) was isolated. To purify the di-epoxidated
dolabellane (7) a ﬂash chromatography was carried out.
Therefore the reaction mixture was dried with MgSO4, ﬁltered
and evaporated under vacuum to dryness. Puriﬁcation was
carried out by ﬂash chromatography over silica (Silica gel 40,
Sigma–Aldrich) utilizing an isocratic 70/30 hexane/ethyl acetate
mobile phase.
Biocatalytical Oxidation of
(1R,3E,7E,11S,12S)-3,7,18-
dolabellatriene by P450BM3
In vitro Assay
For the in vitro assay pET28a(P450BM3_F87A) and, respectively,
pET28a(P450BM3_F87A/A328L) were introduced into E.
coli BL21(DE3) by standard transformation methods. From
an overnight culture (8 h cultivation at 37◦C, LB media
supplemented with 30 μg/mL kanamycin) the cells were grown
to an OD600 0.5 in 100 mL LB media. Subsequently, 1 mM
isopropyl IPTG, 1 mM δ-aminolevulinic acid (ALA), 0.5 mM
FeSO4 × 7H2O and 5 μg/L riboﬂavin was added to the cultures.
Protein expression was done overnight at 25◦C. Next, the cells
were harvested and centrifuged (10.000g for 20 min at 4◦C). The
cell pellet was resuspended in 5 mL 50 mM kaliumphosphate
buﬀer (pH 7.5). The cells were lysed by soniﬁcation using a
Sonoplus HD2070 (Bandelin Electronic) performing ﬁve repeats
on ice (1 min on and 3 min oﬀ at 50% power) and subsequently
centrifuged (20.000g for 20 min at 4◦C). For the assay, 100 μL
supernatant were added to 400 μL 50 mM kaliumphosphate
buﬀer (pH 7.5) supplemented with 200 μM (1R,3E,7E,11S,12S)-
3,7,18-dolabellatriene, which was added in absolute ethanol to a
ﬁnal assay concentration of 0.5% (v/v). The reaction was started
by adding 100 μM NADPH/H+ at 25◦C. After 3 h the reaction
was stopped by addition of 500 μL ethyl acetate. The reaction
mixture was vigorously mixed and the organic phase analyzed by
GC-MS.
In vivo Assay
For the in vivo assay the vectors pCola-Duet-1 (dxr, dxs), pCDF-
Duet-1 (ispD/ispF, idi), pET-Duet-1 (crtE, cotB2W288G), and the
vector pACYC-Duet-1 (P450BM3_F87A / F87A_A328L) were
introduced into E. coli Bl21 (DE3) by standard transformation
procedures. Cultivation was done in shake ﬂasks and the cells
were grown in 400 mL LB medium supplemented with 100 mM
HEPES (pH 7.6), 30 μg/mL kanamycin, 50 μg/mL streptomycin,
50 μg/mL carbenicillin, and 34 μg/mL chloramphenicol
inoculated from an overnight culture with the same media
composition. The cells were grown to an OD600 of 0.8 at
37◦C. Next, 2% (v/v) glycerol, 1 mM δ-aminolevulinic acid
(ALA), 1 mM FeSO4·7H2O and 1 mM isopropyl IPTG were
added and the cells were cultivated at 25◦C for 5 days.
(1R,3E,7E,11S,12S)-3,7,18-dolabellatriene and its hydroxylated
variants were extracted from cells and supernatant separately
after an initial centrifugation step (15min, 17,500 g, 4◦C). The cell
pellet was washed, suspended in 5 mL water, lysed by soniﬁcation
using a Sonoplus HD2070 (Bandelin Electronic) performing ﬁve
repeats on ice (5 min on and 3 min oﬀ at 80% power) and
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subsequently extracted three times with 25 mL ethyl acetate.
The supernatant was extracted three times with 200 mL ethyl
acetate. Organic phases were combined, dried with MgSO4 and
evaporated under vacuum to dryness. The crude extract was
solved in 1 mL ethyl acetate and analyzed by GC-MS.
Molecular Docking of
(1R,3E,7E,11S,12S)-3,7,18-
dolabellatriene in the P450BM3_F87A and
P450BM3_F87A/A328L Active Side
Molecular Docking was performed using the AutoDock Vina
program environment of YASARA structure with the PDB 2X7Y.
PDB 2X7Y already contained the F87A mutation. Docking
simulation was done with P450BM3 F87A and P450BM3
A87A/A328L. The mutation A328L was introduced in the PDB
2X7Y in silico. (1R,3E,7E,11S,12S)-3,7,18-dolabellatriene was
docked into a simulation cell (Size: X-size = 16Å, Y-size = 16 Å,
Z-size = 16 Å, angles: α = 90◦, β = 90◦, γ = 90◦) around
the following four residues Ser 89, Thr 260, Gly 271, and
Pro 329. 999 docking runs were performed while all atoms
of (1R,3E,7E,11S,12S)-3,7,18-dolabellatriene set as rigid. Cluster
analysis were performed in the AutoDock Vina program
environment and characterized by binding energy [kcal/mol],
dissociation constant [pM], and contacting receptor residues.
Results are shown in the Supplementary Material.
Hydroboration–Oxidation of
(1R,3E,7E,11S,12S)-3,7,18-
dolabellatriene
Five micro gram of (1R,3E,7E,11S,12S)-3,7,18-dolabellatriene
(18.4 μmol, 1 eq) and 3.4 mg 9-BBN-Dimer (13.8 μmol, 1.5 eq)
were solved in 1 mL CH2Cl2. The reaction was stirred at
room temperature and the process of the reaction was followed
by thin layer chromatography. After (1R,3E,7E,11S,12S)-3,7,18-
dolabellatriene was completely converted, the reaction mixture
was washed two times with 0.5 mL water. The organic solvent
was evaporated under vacuum to dryness and the residue was
solved in 500 μL MeOH, 400 μL 2M NaOH (aq), and 100 μL
H2O2 (aq) (30%). The mixture was stirred over night at room
temperature. Subsequently, the reaction mixture was extracted
three times with 1 mL Et2O. The organic phases were combined
and evaporated under vacuum to dryness. The crude extract
was solved in 1 mL ethyl acetate and analyzed by GC-MS and
-FID. Puriﬁcation was carried out with a silica (Silica 247 gel
40, Sigma–Aldrich) ﬂash chromatography column applying an
isocratic 90/10 hexane/ethyl acetate gradient.
RESULTS AND DISCUSSION
Optimizing Biotechnological
Dolabellatriene Production
Recovery of (2) from dried algae biomass is limited in yield
and supply. Ioannou et al. (2011) were able to isolate 0.15 mg/g
from the brown algea D. spiralis. Due to the high diversity of
dolabellane in this brown algae the isolation of (2) also involves
extensive puriﬁcation steps. In our previous research we were
able to produce small amouts of (2) (1.7 mg/L) by an E. coli strain
overexpressing the recombinant diterpene biosynthesis pathway
with the DXP pathway enzymes isopentenyl diphosphate
isomerase (idi), 1-deoxyxylulose-5-phosphate synthase (dxs),
1-deoxy-D-xylulose-5-phosphate reductoisomerase (dxr),
geranylgeranyl diphosphate synthase (crtE) and the CotB2
W288G diterpene synthase mutant (Janke et al., 2014). More
recently, we have achieved the microbial biosynthesis of
taxadiene and several other diterpenoids with yields up to
80 mg/L using an E. coli strain overexpressing, additional
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (ispD)
and 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase
(ispF) (Schrepfer et al., submitted). In this study we have used
this improved diterpene production system to improve our
previous reported production yields (Janke et al., 2014). By
integration of the CotB2 W288G synthase mutant into this
enhanced production strain we could increase the yield for
dolabetatriene to 8 mg/L in conventional shake ﬂasks cultures.
The dolabellatriene was recovered from eight independent 1 l
batches of organic extracts. These extracts contained on average
8 mg/L of the target product. The variations between each
batch were minor. This scalable biotechnological production
route enables independent access of (2), which is a prerequisite
for subsequent chemical functionalization studies reported
here.
In this study, we devised selective chemical oxidation
strategies for (2) to generate new dolabellanes with enhanced
or diversiﬁed bioactivities. Conventionally, complex biocatalytic
functionalization of diterpene oleﬁns requires initial oxidative
activation of the oleﬁnic macrocycle, which in vivo is carried
out by highly substrate speciﬁc P450-type oxidoreductases.
Since there are no biocatalysts known in nature that can
functionalize the dolabellatriene macrocycle, we evaluated
chemical and enzymatic methodologies for the regio- and
stereoselective oxidation of (2). The speciﬁc challenge in any
terpene centered semisynthetic approach is the regio- and
stereoselective functionalization of chemically very similar C-H
bonds. In nature selectivity is provided by steric demand of amino
acid residues in the binding pocket of P450 type enzymes (Brück
et al., 2014).
Epoxidation of Dolabellatriene by Lipase
Mediated in situ Generated Peracetic
Acid
In our primary enzymatic based functionalization approach
we focused on production of epoxidized variants of (2). The
structure of (2) is in possession of three oleﬁnic bonds. Two
are located within the 11 membered ring and show an equal
substitution pattern, while the third bond is a terminal alkene
with a low degree of substitution. The selective epoxidation of
the alkene bonds within the bicyclic carbon skeleton provides
the opportunity for the synthesis of (5) and (6), respectively
(Figure 3; Ioannou et al., 2011). Since epoxidation by chemical
methods is strongly in favor for higher substituted and therefore
more reactive dienes, the terminal oleﬁnic bond is discriminated.
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FIGURE 3 | (A,B) Epoxidation reaction of (1R,3E,7E,11S,12S)-3,7,18-dolabellatriene (2). (C) Key NOESY correlations of (7).
Previously, the semisynthetic transformation of (2) to the
natural, bioactive compounds (5), and (6) has been demonstrated
using m-chloroperbenzoic acid, a highly reactive peracid
(Ioannou et al., 2011). We evaluated the selectivity of the time
resolved epoxidation of 15 mg (2) using the less reactive acetic
peracid. The reaction was performed in ethyl acetate, containing
acetic peracid that was formed in situ by reaction of immobilized
lipase B (C. antarctica) with H2O2 and catalytic amounts of
acetic acid (Da Silva and Nascimento, 2012). The progress of the
reaction was monitored by GC-MS analysis (Figure 3B). After
4.5 h the highest concentration of a mixture containing equal
amounts of (5) and (6) was detected [58% (5.1 mg, 56% (5);
4.1 mg, 44% (6)]. At 23 h the yield of (5) and (6) decreased
(53% [4.8 mg, 57% (5); 3.7 mg, 43% (6))], while the new, di-
expoxidated diterpene species (7) was formed. The yields of (5)
and (6) observed in this study are similar to those reported for the
equivalent reaction in the presence of m-chloroperbenzoic acid,
which provided 56% [48% (6); 52% (5)] after 30 min (Ioannou
et al., 2011).
The conversion of (5) and (6) to (7) was a rather slow process
with a 43% (7.2 mg) yield obtained after 50 h, when the reaction
was terminated. In this timeframe (5) and (6) decreased to
37% [55%, 3.2 mg (5); 45%, 2.7 mg (6)]. Interestingly, toward
the end of the reaction a tri-epoxidated diterpene (8) was
generated with a limited yield of 1.8% (0.3 mg). Examination
of the stereochemistry indicated that the epoxidation of (2)
was very selective. Since the structure of the non-natural
dolabellane (7) has not been reported so far, we carried out a
comprehensive structural analysis (Figure 3C, Supplementary
Material). GC-MS and NMR analysis revealed that about
90% of the di-epoxidated (7) had the same conﬁguration.
Key NOE correlations from NOSEY NMR spectroscopy were
observed between H-3/H-7, H-3/H3-15, H-2β/H-3, H-7/H-9β,
H-7/H3-15 and H-2α/H-12 (Figure 3C) indicating that the
C15-methyl group is at the same side of the molecule as
the hydrogens H-3 and H-7 positioned at the epoxy groups.
Consequently, the epoxides in (7) are likely to display a (S, S)
conﬁguration (Supplementary Material). Therefore (7) can be
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described as (1R,3S,4S,7S,8S,11S,12S)-3,4,7,8-diepoxy-dolabella-
18-ene. The preference for a certain epoxide conformation can
be explained by the higher thermodynamic stability of the (S, S)
epoxide compared to the (R, R) counterpart. Nevertheless, during
epoxidation the formation of several side products were observed
by GC-MS analysis, which may include formation of the (R,
R) epoxides. A time resolved monitoring of the lipase mediated
dolabellatriene epoxidation allows selective enrichment of either
(5), (6), or (7), respectively. Speciﬁcally, increased concentrations
of (5) and (6) can be obtained by premature termination of
the reaction after 4.5–23 h. Separation of the resulting products
(5) and (6) can be achieved according to previously reported
protocols (Ioannou et al., 2011). In contrast to procedures leading
to the predominant formation of either (5) or (6), enrichment
of the di-epoxy diterpene (7) requires extended reaction times
beyond 30 h. The long reaction times for this side reaction
can be reasoned as epoxidation of the terminal oleﬁn group is
particularly slow. The resulting products (5), (6), or (7) may be
used in a variety of consecutive reactions due to the diversity of
epoxide chemistry.
Stereoselective Hydroxylation of
Dolabellatriene by P450BM3
In our next enzymatic based functialization approach we focused
on functionalization of the less reactive terminal oleﬁnic bond (C-
20 C-18) of dolabellatriene. We aimed to transform the oleﬁnic
bond into a hydroxyl group, which potentially leads to the
production of the more potent dolabellane (4) (Ioannou et al.,
2011) or related structures.
Prior to our chemical synthesis approach we elucidated the
application of the well-studied hydroxylase P450BM3 derived
from B. megaterium. The enzyme is known to catalyze the
hydroxylation of long chain and saturated fatty acids. P450BM3
is a fusion protein of a P450 catalytic unit and its corresponding
redox system, which displays the highest turnover rate of
any currently reported P450 enzyme system (Whitehouse
et al., 2012). Consequently, it has been heavily engineered
to hydroxylate natural and non-natural substrates, including
macrocyclic diterpenoid skeletons (Urlacher and Girhard, 2012).
In the case of the sesquiterpenoid macrocycle, amorpha-4-
11-diene (9) an engineered P450BM3 (F87A/A328L) was able
to oxidize the terminal oleﬁnic group to artemisinic-11S,12-
epoxide (9a) (Dietrich et al., 2009). More recently, it has been
reported that P450BM3 F87A is also capable of oxidizing the bi-
hydroxylated diterpenoid β-cembrenediol (Le-Huu et al., 2015).
Since epoxides can be used in a variety of consecutive reactions,
application of an equivalent approach to generate (10) (Figure 4)
would be very useful. As the epoxidation of (2) is more sterically
demanding than (9), we primarily evaluated the feasibility of
this strategy by in silico docking experiments (Supplementary
Material). The docking experiments did provide an indication
that (2) may be a substrate for P450BM3 (Supplementary
Figure S12). Consequently, we generated mutants P450BM3
F87A and/or A328L, which have been reported to achieve
epoxidation of amorpha-4-11-diene. The P450BM3 mutants
were recombinantly expressed and tested in an in vitro assay
FIGURE 4 | P450BM3 facilitated oxidation of amorpha-4-11-diene.
supplemented with (2). At the end of the assay (3 h) the
terpenoids were extracted, concentrated and analyzed by GC/MS.
However, none of the assays showed the formation of an
oxidized diterpene. The conversion of (2) by the P450BM3
mutants might be very slow, suﬀer from inhomogeneous
distribution of the substrate and/or result in yields below the
limit of detection. Subsequently, we introduced the P450BM3
mutants in our E. coli based dolabellatriene production system
to increase the reaction time and therefore the quantity of
potential products. The E. coli strain in this in vivo assay was
cultivated for 5 days followed by a detailed GC/MS analysis.
Again we were not able to detect any hydroxylated products,
indicating that (2) was not a substrate for any of the P450BM3
mutants under our investigation. Based on these experimental
results, we conclude that our in silico docking experiments
may have underestimated the steric demands of (2) in the
enzyme active site. Alternatively it may be argued that an initial
introduction of at least one hydroxyl function in the diterpene
macrocycle may assist substrate binding and orientation in close
proximity to the catalytically active heme iron center. This
molecular templating interaction in the active site of P450BM3
may explain the successful hydroxylation of β-cembrenediol
(Le-Huu et al., 2015). Conversely, for the smaller amorpha-
4-11-diene no additional functionalization may be required to
mediate binding in close proximity to the catalytically active
center. More generally, it can be stated that at present in silico
calculations do provide any guarantees that particular reactions
will take place. However, feedback with experimental data
combined with rapid improvements in bioinformatic algorithms
may in future facilitate the precise prediction of enzymatic
reactions.
Alternative enzyme activities, such as chloroperoxidase, which
have been reported to oxidatively activate a variety of terpenes
may eventually be capable of utilizing (2) as a substrate (Águila
et al., 2008; Piantini et al., 2011). We are currently following up
with a diﬀerent strategy, involving high throughput mutagenesis
of the class one hydroxylase CotB3, which is naturally involved
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FIGURE 5 | (A) Hydroboration–oxidation reaction of (1R,3E,7E,11S,12S)-3,7,18-dolabellatriene (11). (B) NOESY correlation between H-20α/H3-19 and
H-20β/H2-13 in (2) (C) Key NOESY correlations for (11).
in formation of cyclooctatin. The rationale behind this approach
is the structural similarity of (2) with the native CotB3 substrate
cyclooctat-9-en-7-ol.
Stereoselective Hydroxylation of
Dolabellatriene via a Hydroboration
Strategy
As current enzymatic strategies for hydroxylation of (2) were not
successful, we evaluated alternative chemical routes for regio-
and stereoselective hydroxylation. In order to regio-selectively
access the terminal alkene, we evaluated monohydroboration
for target orientated hydroxylation. Bulky dialkylboranes are
reported to be exceptionally regioselective for terminal alkenes
on various substituted dienes (Graham et al., 2011). The
resulting trialkylboranes can be used in numerous subsequent
reactions to produce alcohols, amines, alkylation, and C-C
coupling. Mechanistically, hydroboration is generally an anti-
markovnikov reaction, resulting in formation of a primary
alcohol after oxidation of the dialkylboranes. Subsequently,
we utilized 5 mg of (2) as a substrate, which was primarily
reacted with 9-borabicyclo[3.3.1]nonane (9-BBN-H) followed
by an oxidative step with H2O2/NaOH. The resulting reaction
mixture was analyzed by GC-MS/FID, resulted in detection
of two hydroxylation products of (2). One of these alcohols
was formed in an enantiomeric excess (ee) of 94%. The data
indicated that the hydroboration reagent preferentially added to
one speciﬁc side of the terminal oleﬁnic group. The yield of the
prominent alcohol (11) was determined. After puriﬁcation the
yield of the prominent alcohol (11) was 84% (4.5 mg) with respect
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to the substrate and was subsequently elucidated by 1D and 2D
NMR spectroscopy (Supplementary Material). This is the ﬁrst
instance that compound (11) is reported.
Structure analysis conﬁrmed the stereoselective formation of
a primary alcohol (11) at the terminal oleﬁnic bond (C-20)
(Supplementary Figure S11). The outcome of the hydroboration
reaction primarily depends on the position of the terminal alkene
group. While in the educt (2), the bond between C-12 and C-18
allows free rotation, NOE correlations betweenH-20α/H3-19 and
H-20β/H2-13 in (2) clearly assign the position of the terminal
alkene group to point away from the 11-membered ring of (2)
(Figure 5B). Consequently, mechanistic considerations indicate
that the terminal alkene group in (2) (see Figure 5A) is only
accessible to si face in the syn addition of 9-BBN, while the re
side is sterically hindered due to the CH2 groups at C9/10 and the
C15 methyl group, respectively (Figure 5A). The stereochemistry
of the newly formed stereo center at C18 was elucidated by
NOESY NMR spectroscopy. Key NOE correlations of (11)
were observed between H2-20/H-13, H2-20/ H3-19, H2-20/H-
18, H3-19/H-9β, H3-19/H-18 and are illustrated in Figure 5B. In
agreement with the observed NOE correlations we suggest the
formation of the alcohol (1R,3E,7E,11S,12S,18R)-dolabella-3,7-
diene-20-ol (Figure 5C). This is the ﬁrst report of a stereoselective
hydroboration of a triene-diterpenoid macrocycle.
CONCLUSION
We demonstrated that a sustainable, biotechnological production
of the bioactive (1R,3E,7E,11S,12S)-3,7,18-dolabellatriene (2)
by the mutant diterpene cyclase CotB2 W288G is feasible.
This independent route provides access to suﬃcient material
used in subsequent enzymatic and chemical approaches to
generate an oxidatively activated macrocycle. Our strategies
allowed access of a variety of natural as well as new, non-
natural dolabellanes with high regio- and stereo-selectivity. In
particular, we could demonstrate that monohydroboration of the
diﬀerentially substituted terminal triene 3,7,18-dolabellatriene
is highly stereoselective. Subsequent oxidation yields the new,
non-natural compound (1R,3E,7E,11S,12S,18R)-dolabella-3,7-
diene-20-ol (11). Consequently, hydroborations may be used
in dolabellanes macrocycles to selectively functionalize the
terminal alkene group. In a complementary approach we could
demonstrate the eﬃcient epoxidation of (2) by peracetic acid,
which was formed in situ using a lipase catalyzed conversion
of acetic acid and H2O2, resulting in products (5), (6), (7),
(8). By temporal monitoring of the resulting reaction mixture
it is possible to selectively enrich these products. In this
study we could demonstrate that combining biotechnological,
chemo-enzymatic, and chemical reaction cascades for the
eﬃcient and scalable production of oxidatively activated
diterpene macrocycles. The resulting reaction products may
inherently display improved bioactivity compared to their parent
compound. Alternatively, these chemically activated compounds
may serve as synthons for more elaborate synthesis toward highly
functionalized natural and non-natural dolabellanes.
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